The positive efficacy of dexmedetomidine on the clinical outcomes of patients undergoing renal transplantation: evidence from meta-analysis
Aging · 2023-12-15 · 15 (23) · 14192-14209
DOI: 10.18632/aging.205296 ↗At a glance
Metaanalyse in Aging, published online on 2023-12-11. Written by Shanshan Guo and 6 co-authors. Institution: Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, PR China. Major MEDLINE topics: Dexmedetomidine, Kidney Transplantation. Cited 2 times so far (Crossref); 41 references. The full text is freely available in PubMed Central.
Abstract (original language)
INTRODUCTION: Whether dexmedetomidine (DEX), an anesthetic adjuvant, can improve renal transplant outcomes is not clear. METHODS: We systematically identified clinical trials in which DEX was administered in renal transplantation (RT). On November 1, 2022, we searched The Cochrane Library, MEDLINE, EMBASE and https://www. CLINICALTRIALS: gov/. The main outcomes were delayed graft function and acute rejection. RESULTS: A total of seven studies were included in the meta-analysis. The results showed that compared with the control, DEX significantly reduced the occurrence of delayed graft function (RR 0.76; 95% CI 0.60-0.98), short-term serum creatinine [postoperative day (POD) 2: (MD -22.82; 95% CI -42.01 - -3.64)] and blood urea nitrogen [POD 2: (MD -2.90; 95% CI -5.10 - -0.70); POD 3: (MD 2.07; 95% CI -4.12 - -0.02)] levels, postoperative morphine consumption (MD -4.27; 95% CI -5.92 - -2.61) and the length of hospital stay (MD -0.85; 95% CI-1.47 - -0.23). However, DEX did not reduce the risk of postoperative acute rejection (RR 0.75; 95% CI 0.45-1.23). The results of the subgroup analysis showed that country type, donor type, and average age had a certain impact on the role of DEX. CONCLUSIONS: DEX may improve the short-term clinical outcome of RT and shorten the length of hospital stay of patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, PR China.
- Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China.
- Center for Scientific Research of Anhui Medical University, Hefei, Anhui 230022, PR China.
Cite
APA
Guo, S., Jia, D., Liu, X., Gao, L., Wang, H., Chen, C., & Wu, Y. (2023). The positive efficacy of dexmedetomidine on the clinical outcomes of patients undergoing renal transplantation: evidence from meta-analysis. Aging, 15(23), 14192-14209. https://doi.org/10.18632/aging.205296
Vancouver
Guo S, Jia D, Liu X, Gao L, Wang H, Chen C, et al. The positive efficacy of dexmedetomidine on the clinical outcomes of patients undergoing renal transplantation: evidence from meta-analysis. Aging. 2023;15(23):14192-14209. doi:10.18632/aging.205296
BibTeX
@article{Guo2023,
author = {Guo, Shanshan and Jia, Degong and Liu, Xueqi and Gao, Li and Wang, Huaying and Chen, Chaoyi and Wu, Yonggui},
title = {The positive efficacy of dexmedetomidine on the clinical outcomes of patients undergoing renal transplantation: evidence from meta-analysis},
journal = {Aging},
year = {2023},
volume = {15},
number = {23},
pages = {14192--14209},
doi = {10.18632/aging.205296}
}
EUVIMED